Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

The globalization of inflammatory bowel disease

the incidence and prevalence of inflammatory bowel disease in Brazil

Quaresma, Abel B.a; Kaplan, Gilaad G.b; Kotze, Paulo G.c

Current Opinion in Gastroenterology: July 2019 - Volume 35 - Issue 4 - p 259–264
doi: 10.1097/MOG.0000000000000534
INFLAMMATORY BOWEL DISEASE: Edited by Miguel Regueiro
Buy

Purpose of review Epidemiological studies of inflammatory bowel disease (IBD) in newly industrialized countries are limited, due to a lack of medical surveillance systems and reliable and unified registries and databases. In Brazil, reliable data on the incidence and prevalence of Crohn's disease and ulcerative colitis is scarce. The objective of the present review is to describe in detail the available data on the incidence and prevalence of Crohn's disease and ulcerative colitis in Brazil.

Recent findings The authors identified the single four population-based studies which refer to incidence and prevalence of IBD in the country (two from São Paulo, one from Espírito Santo and one from the state of Piauí). These studies demonstrate a remarkable growth in the incidence and estimated prevalence of IBD in Brazil, with higher number of cases in more developed regions.

Summary The increase in incidence over time and the higher current prevalence are indicative of a historical progression in relation to the number of IBD patients in our country, similar to what was observed in countries from Asia and approximating those of the northern hemisphere. Epidemiological studies with more accurate methodology are needed in Brazil.

aWest Santa Catarina State University (UNOESC), Joaçaba, Brazil

bUniversity of Calgary, Calgary, Alberta, Canada

cCatholic University of Paraná (PUCPR), Curitiba, Brazil

Correspondence to Paulo G. Kotze, MD, PhD, Catholic University of Paraná (PUCPR), Rua Bruno Filgueira, 269 CJ. 1205, Curitiba CEP 80440-220, PR, Brazil. Tel: +55 41 32430033; e-mail: pgkotze@hotmail.com

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.